{
    "medicine_id": "0c3afb24a8bd9db794d8b035f5b3e2a485d07282",
    "platform_id": "DB13761",
    "metadata": {
        "name": "Dairy Digestive Aid Tab 3000fcc Lactase Unit 2250 U Tablet chewable",
        "composition": "2250 U Tilactase",
        "clinical_particulars": {
            "therapeutic_indications": "Tilactase is indicated for the symptomatic treatment of lactose intolerance in infants and older patients requiring a parenteral nutrition or fluid diet L2338 Lactose intolerance occurs when there is an existence of an inability to break down lactose which is commonly found in dairy products This inability occurs when the lactase levels are reduced and thus there is no via to digest and break down the lactose The undigested lactose moves into the large intestine where normal flora bacteria can interact with it and cause bloating gas and diarrhea A32592",
            "contraindications": {
                "disease": "Tilactase is known to present a low acute oral toxicity in preclinical trials The lowest toxic dose for subcutaneous exposure is of 26 g kg administered over 30 days L2340 There have not been performed enough studies regarding the use of pregnancy or related to the fetal development There are no reports of overdose with tilactase L2345",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "The use of a single oral administration of tilactase has been shown to be highly effective in decreasing the symptoms and hydrogen excretion of hypolactasia in tests of lactose H 2 breath The analysis has shown a decrease of approximately 80 in both malabsorbers and intolerants A27172 The administration of tilacatase also decreases the presence of bloating and flatus A27173",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}